Hepatitis B Virus (HBV) Screening and Diagnosis (Triple Panel)
Use
This is a triple test panel intended for screening and diagnosis of hepatitis B virus (HBV) infection. This panel can be used to identify different phases of HBV infection and to determine whether a patient has acute or chronic HBV infection, is immune to HBV as a result of prior infection or vaccination, or is susceptible to infection. This panel aligns with current CDC recommendations for HBV screening and testing.
Special Instructions
Not provided.
Limitations
The panel's performance has not been established with cadaveric specimens, heat-inactivated specimens, or body fluids other than serum and EDTA plasma. Incorrect handling or atypical storage conditions may affect the test outcome. Interference from high doses of biotin supplements is possible, affecting test accuracy.
Methodology
Immunoassay (CLIA)
Biomarkers
LOINC Codes
- 77190-7 - HBV core + surf Ab + surf Ag Pnl Ser
- 5196-1 - HBV surface Ag SerPl Ql IA
- 22322-2 - HBV surface Ab Ser Ql
- 13952-7 - HBV core Ab SerPl Ql IA
- 77202-0 - Laboratory comment Report
- 56850-1 - Imp & review of lab results
Result Turnaround Time
1-2 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
5 mL
Minimum Volume
2.5 mL
Container
Gel-barrier tube, red-top tube or serum transfer tube
Collection Instructions
If a tube other than a gel-barrier tube is used, transfer separated serum to a screw-cap polypropylene transport tube. Do not freeze gel-barrier tube (pour off serum first).
Patient Preparation
No special preparation required.
Storage Instructions
Room temperature
Causes for Rejection
Specimens other than serum or EDTA plasma; PST gel-barrier tube; specimens with visible gross microbial contamination
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 14 days |
| Frozen | 14 days |
Other tests from different labs that may be relevant